急性缺血性卒中患者的肾功能增强清除:一项前瞻性观察性研究
本研究为单中心前瞻性观察性研究,纳入社区医院神经重症ICU收治的成人急性缺血性卒中患者,采用24小时尿液收集测定肌酐清除率,主要终点为肾功能增强清除(实测肌酐清除率>130 mL/min),次要终点为神经重症ICU住院时长。28例符合入组标准,最终分析20例,35%的入组患者存在肾功能增强清除。肾功能数学估算方法不足以检出肾功能增强清除的表现。发生肾功能增强清除的患者与神经重症ICU住院时长非显著缩短相关。作者结论为肾功能增强清除在急性缺血性卒中患者中表现不一致。
要点
- 急性缺血性卒中患者中35%存在肾功能增强清除,定义为实测肌酐清除率>130 mL/min。
- 肾功能数学估算方法不足以检出急性缺血性卒中患者的肾功能增强清除。
- 发生肾功能增强清除的患者与神经重症ICU住院时长非显著缩短相关。
- 28例符合入组标准,最终对20例患者数据进行分析。
- 作者结论:肾功能增强清除在急性缺血性卒中患者中表现不一致。
适用人群与场景
- 社区医院神经重症ICU收治的成人急性缺血性卒中患者,入组后行24小时尿液收集测定肌酐清除率。
诊断标准与关键阈值
- 肾功能增强清除定义为实测肌酐清除率>130 mL/min。
研究设计与关键结果
- 单中心前瞻性观察性研究,28例符合入组标准,最终分析20例患者数据。
- 35%的入组患者存在肾功能增强清除。
- 肾功能数学估算方法不足以检出肾功能增强清除的表现。
- 发生肾功能增强清除的患者与神经重症ICU住院时长非显著缩短相关。
证据类型、等级与局限
- 证据类型:单中心前瞻性观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:肾功能增强清除在急性缺血性卒中患者中表现不一致;肾功能数学估算方法不足以检出肾功能增强清除。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Augmented renal clearance (ARC) is a phenomenon that has been demonstrated in many subsets of critically ill patients and is characterized by a creatinine clearance (CrCl) > 130 mL/min. Prior research has examined ARC prevalence in the presence of sepsis, traumatic brain injury, subarachnoid hemorrhage, and intracranial hemorrhage. However, to our knowledge, no studies have examined whether this phenomenon occurs in patients suffering from an acute ischemic stroke (AIS). The objective of this study was to evaluate whether patients experiencing an AIS exhibit ARC, identify potential contributing factors, and examine the precision of current renal clearance estimation methods in patients with AIS experiencing ARC.
METHODS: This was a single-center prospective observational study conducted in adult patients admitted to a neurocritical intensive care unit (ICU) at a community hospital. Once consent was gained, patients with an admitting diagnosis of an AIS underwent a 24-h urine collection to assess measured CrCl. The primary end point assessed for ARC, defined as a measured CrCl > 130 mL/min. The secondary end point evaluated length of stay in the neurocritical ICU.
RESULTS: Twenty-eight patients met enrollment criteria, and data was analyzed for 20 patients. ARC was present in 35% of enrolled patients. Mathematical estimations of renal function were inadequate in detecting ARC manifestation. Patients experiencing ARC were associated with nonsignificantly shorter ICU length of stay.
CONCLUSIONS: ARC appears to manifest in patients with AIS inconsistently. Patients experiencing ARC were associated with nonsignificantly shorter ICU length of stay.
参考来源
- John G, Heffner E, Carter T, et al. Augmented Renal Clearance in Patients with Acute Ischemic Stroke: A Prospective Observational Study. Neurocrit Care. 2022. PMID: 35918629. doi:10.1007/s12028-022-01569-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。